Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/NSI-189> ?p ?o }
Showing triples 1 to 83 of
83
with 100 triples per page.
- NSI-189 abstract "NSI-189 is an experimental drug being studied by Neuralstem, Inc. Research into NSI-189 has been funded by the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) for the treatment of major depressive disorder.".
- NSI-189 casNumber "1270138-40-3".
- NSI-189 iupacName "(4-Benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone".
- NSI-189 pubchem "50922681".
- NSI-189 thumbnail NSI-189_structure.svg?width=300.
- NSI-189 wikiPageID "40541446".
- NSI-189 wikiPageLength "4246".
- NSI-189 wikiPageOutDegree "26".
- NSI-189 wikiPageRevisionID "707012019".
- NSI-189 wikiPageWikiLink 4-Chlorokynurenine.
- NSI-189 wikiPageWikiLink Alzheimers_disease.
- NSI-189 wikiPageWikiLink samidorphan.
- NSI-189 wikiPageWikiLink CERC-301.
- NSI-189 wikiPageWikiLink CERC-501.
- NSI-189 wikiPageWikiLink Category:Antidepressants.
- NSI-189 wikiPageWikiLink Category:Drugs_with_unknown_mechanisms_of_action.
- NSI-189 wikiPageWikiLink Category:Nicotinamides.
- NSI-189 wikiPageWikiLink Category:Nootropics.
- NSI-189 wikiPageWikiLink Category:Piperazines.
- NSI-189 wikiPageWikiLink Category:Pyridines.
- NSI-189 wikiPageWikiLink Clinical_trial.
- NSI-189 wikiPageWikiLink DARPA.
- NSI-189 wikiPageWikiLink Esketamine.
- NSI-189 wikiPageWikiLink Experimental_drug.
- NSI-189 wikiPageWikiLink Major_depressive_disorder.
- NSI-189 wikiPageWikiLink Memory_and_aging.
- NSI-189 wikiPageWikiLink NRX-1074.
- NSI-189 wikiPageWikiLink National_Institutes_of_Health.
- NSI-189 wikiPageWikiLink Neuralstem,_Inc..
- NSI-189 wikiPageWikiLink Neurological_disorder.
- NSI-189 wikiPageWikiLink Phase_1.
- NSI-189 wikiPageWikiLink Posttraumatic_stress_disorder.
- NSI-189 wikiPageWikiLink Rapastinel.
- NSI-189 wikiPageWikiLink Stroke.
- NSI-189 wikiPageWikiLink Traumatic_brain_injury.
- NSI-189 wikiPageWikiLinkText "NSI-189".
- NSI-189 c "22".
- NSI-189 casNumber "1270138".
- NSI-189 chemspiderid "32701740".
- NSI-189 eliminationHalfLife "17.4".
- NSI-189 h "30".
- NSI-189 inchi "1".
- NSI-189 inchikey "DYTOQURYRYYNOR-UHFFFAOYAL".
- NSI-189 iupacName "-[2-pyridin-3-yl]methanone".
- NSI-189 legalStatus "Unscheduled".
- NSI-189 molecularWeight "366.4998".
- NSI-189 n "4".
- NSI-189 o "1".
- NSI-189 pregnancyUs "N".
- NSI-189 pubchem "50922681".
- NSI-189 routesOfAdministration "Oral".
- NSI-189 smiles "CCCCNC1=CCN2CCNCC3=CC=CC=C3".
- NSI-189 stdinchi "1".
- NSI-189 stdinchikey "DYTOQURYRYYNOR-UHFFFAOYSA-N".
- NSI-189 width "200".
- NSI-189 wikiPageUsesTemplate Template:Antidepressants.
- NSI-189 wikiPageUsesTemplate Template:Drugbox.
- NSI-189 wikiPageUsesTemplate Template:Neurotrophinergics.
- NSI-189 wikiPageUsesTemplate Template:Nootropics.
- NSI-189 wikiPageUsesTemplate Template:Reflist.
- NSI-189 wikiPageUsesTemplate Template:Stdinchicite.
- NSI-189 subject Category:Antidepressants.
- NSI-189 subject Category:Drugs_with_unknown_mechanisms_of_action.
- NSI-189 subject Category:Nicotinamides.
- NSI-189 subject Category:Nootropics.
- NSI-189 subject Category:Piperazines.
- NSI-189 subject Category:Pyridines.
- NSI-189 hypernym Drug.
- NSI-189 type ChemicalSubstance.
- NSI-189 type Drug.
- NSI-189 type ChemicalObject.
- NSI-189 type Thing.
- NSI-189 type Q8386.
- NSI-189 comment "NSI-189 is an experimental drug being studied by Neuralstem, Inc. Research into NSI-189 has been funded by the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) for the treatment of major depressive disorder.".
- NSI-189 label "NSI-189".
- NSI-189 sameAs Q15409359.
- NSI-189 sameAs m.0x215j8.
- NSI-189 sameAs NSI-189.
- NSI-189 sameAs NSI-189.
- NSI-189 sameAs Q15409359.
- NSI-189 wasDerivedFrom NSI-189?oldid=707012019.
- NSI-189 depiction NSI-189_structure.svg.
- NSI-189 isPrimaryTopicOf NSI-189.